DRUG ACTIVE INGREDIENT ESOMEPRAZOLE THIS PEL 40MG (VETERINARY PHARMACEUTICAL INDUSTRY WILL NOT BE USED IN HUMAN MEDICATION ACTIVE ITEM)
DRUG ACTIVE INGREDIENT ESOMEPRAZOLE THIS PEL 40MG (VETERINARY PHARMACEUTICAL INDUSTRY WILL NOT BE USED IN HUMAN MEDICATION ACTIVE ITEM)
04-April-2023
300320000000
CLINICAL RESEARCH DRUGS TO BE USED IN THE TREATMENT OF ADULT PATIENTS WITH GENERALIZED PUSTULAR PSORIASIS ANB19302 FIVE (5) IMSIDOLIMAB (ANB019) 100 MGML OR PLACEBO VIAL
CLINICAL RESEARCH DRUGS TO BE USED IN THE TREATMENT OF ADULT PATIENTS WITH GENERALIZED PUSTULAR PSORIASIS ANB19302 FIVE (5) IMSIDOLIMAB (ANB019) 100 MGML OR PLACEBO VIAL
27-April-2023
300390000000
DRUG ACTIVE INGREDIENT ESOMEPRAZOLE THIS PEL 40MG (VETERINARY PHARMACEUTICAL INDUSTRY WILL NOT BE USED IN HUMAN MEDICATION ACTIVE ITEM)
DRUG ACTIVE INGREDIENT ESOMEPRAZOLE THIS PEL 40MG (VETERINARY PHARMACEUTICAL INDUSTRY WILL NOT BE USED IN HUMAN MEDICATION ACTIVE ITEM)